Application of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012
Diabetes & Metabolism Journal
; : 38-50, 2017.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-222883
Responsible library:
WPRO
ABSTRACT
BACKGROUND:
The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guideline for the treatment of blood cholesterol recommends statin therapy for individuals at high risk of atherosclerotic cardiovascular disease (ASCVD). The aim of this study was to investigate serial trends in the percentages of Korean adults considered eligible for statin therapy according to the new ACC/AHA cholesterol guideline.METHODS:
Data from the Korean National Health and Nutrition Examination Survey (KNHANES) I (1998, n=7,698), II (2001, n=5,654), III (2005, n=5,269), IV (2007 to 2009, n=15,727), and V (2010 to 2012, n=16,304), which used a stratified, multistage, probability sampling design, were used as representative of the entire Korean population.RESULTS:
The percentage of adults eligible for statin therapy according to the ACC/AHA cholesterol guideline increased with time 17.0%, 19.0%, 20.8%, 20.2%, and 22.0% in KNHANES I, II, III, IV, and V, respectively (P=0.022). The prevalence of ASCVD was 1.4% in KNHANES I and increased to 3.3% in KNHANES V. The percentage of diabetic patients aged 40 to 75 years with a low density lipoprotein cholesterol levels of 70 to 189 mg/dL increased from 4.8% in KNHANES I to 6.1% in KNHANES V. People with an estimated 10-year ASCVD risk ≥7.5% and aged 40 to 75 years accounted for the largest percentage among the four statin benefit groups 9.1% in KNHANES I and 11.0% in KNHANES V.CONCLUSION:
Application of the 2013 ACC/AHA guideline has found that the percentage of Korean adults in the statin benefit groups has increased over the past 15 years.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Cardiovascular Diseases
/
Nutrition Surveys
/
Cholesterol
/
Prevalence
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Atherosclerosis
/
American Heart Association
/
Heart
/
Korea
/
Cholesterol, LDL
Type of study:
Practice guideline
/
Prevalence study
/
Qualitative research
Limits:
Adult
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Diabetes & Metabolism Journal
Year:
2017
Document type:
Article